FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 607 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Altering Diet Enhances Response to Cancer Treatments in Mice September 3, 2019 Berry Recipes August 14, 2020 Rebuilding My Life After Cancer and Intensive Treatment: A Survivor’s Story February 9, 2023 Professional Runner and Mom of Two Shares Photo Of Belly Cavity... September 17, 2019 Load more HOT NEWS Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly... ESMO Joins the European Health Alliance on Alcohol (EHAA) Seeking to... Ex-NFL Player Pays For 500 Mammograms To Honor Late Mom Who... Significant Benefits of Nivolumab Plus Cabozantinib Over Sunitinib in Previously Untreated...
